Advances in Noninvasive Prenatal Testing (NIPT) For Down Syndrome and other Trisomies (Online CE Course)

(based on 115 customer ratings)

Author: David J. Moffa, PhD, BCLD
Reviewer: Jenny Camele, MLS(ASCP)

How to Subscribe
MLS & MLT Comprehensive CE Package
Includes 176 CE courses, most popular
$109Add to cart
Pick Your Courses
Up to 8 CE hours
$55Add to cart
Individual course$25Add to cart

Recently, the development of more sensitive and specific molecular test methods has moved us closer to replacing invasive prenatal procedures that are currently needed to confirm certain chromosomal abnormalities. This course discusses both the prenatal screening tests that are routinely used today and new molecular methods that offer new hope for noninvasive prenatal testing to diagnose the presence of Down syndrome or other trisomies.

See all available courses

Continuing Education Credits

P.A.C.E.® Contact Hours (acceptable for AMT, ASCP, and state recertification): 1.5 hour(s)
Approved through 5/31/2026
Florida Board of Clinical Laboratory Personnel Credit Hours - General (Molecular Pathology): 1.5 hour(s)
Approved through 5/31/2026

Objectives

  • Define aneuploidy and trisomy and describe the three most common fetal trisomies.
  • Discuss prenatal screening tests and diagnostic tests that are routinely used for detection of Down syndrome and other trisomies.
  • Describe the cell-free fetal DNA test (cffDNA) and discuss its application as a noninvasive prenatal testing (NIPT) method for trisomy risk assessment.
  • Describe various cell-free DNA (cfDNA) tests commercially available for the prenatal assessment of aneuploidy.
  • Discuss recommendations and guidelines for the use of NIPT as a screening tool for fetal aneuploidy.

Customer Ratings

(based on 115 customer ratings)

Course Outline

Click on the links below to preview selected pages from this course.

Additional Information

Level of Instruction: Intermediate
Intended Audience: Medical laboratory scientists, medical technologists, and technicians. This course is also appropriate for medical laboratory science students and pathology residents.
Author Information:  David Moffa, PhD, has over 30 years of experience in the health care industry as an executive manager, clinical laboratory director, and medical laboratory scientist. He is currently a technical consultant for Kentmere Healthcare, Wilmington, DE, and until his retirement, was the Regional Director for LabCorp, Inc. He holds a PhD in medical biochemistry from the School of Medicine at West Virginia University.
Reviewer Information: Prior to her retirement in 2012, Jenny Camele was employed by Laboratory Corporation of America as the manager of customer service operations for the Fairmont West Virginia Region and a Quality Assurance committee member. She holds a Bachelor of Science degree in Medical Technology from West Virginia University.

How to Subscribe
MLS & MLT Comprehensive CE Package
Includes 176 CE courses, most popular
$109Add to cart
Pick Your Courses
Up to 8 CE hours
$55Add to cart
Individual course$25Add to cart
110220 Trisomies cover 4


MPSS


MPSS sequencing